AstraZeneca’s Strong Start to 2025: Financial Growth and Strategic Collaborations Propel Future Success
AstraZeneca PLC kicked off 2025 with strong financial results, including a 7% increase in product revenue, and strategic collaborations that position the company for future success.
2 minutes to read